It is disclosed for treating the method for suffering from autoimmune disease. The method of application program includes exhausting circulating lymphocyte first in mammal, such as, during applying Anti-thymocyte serum, then population recovery, gives a effective amount of potential TGF-β of mammalian therapeutic and/or another reagent promotes expansion regulatory T cells. In a particular aspect, disclosed method causes to improve renal function and survival rate.